Author

C. T. DeMarco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:non-human primate· 3 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

D. Li· 3 shared D. R. Martinez· 3 shared E. Lee· 3 shared K. Mansouri· 3 shared L. L. Sutherland· 3 shared M. Barr· 3 shared R. J. Edwards· 3 shared R. Parks· 3 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. Li

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyNature CommunicationsPeer-reviewedOct 23, 2022

Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine

D. Li, D. R. Martinez, A. Schäfer…·B. F. Haynes

This study shows a nanoparticle vaccine induces broad neutralizing antibodies against multiple SARS-CoV-2 variants and protects non-human primates and mice from viral challenges.

DOI 10.1038/s41467-022-33985-4

non-human primatemouse

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 17, 2021

SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys

K. O. Saunders, E. Lee, R. Parks…·B. F. Haynes

This study shows that SARS-CoV-2 vaccines induce neutralizing antibodies against SARS-CoV-1, SARS-CoV-2, and batCoVs in monkeys.

DOI 10.1101/2021.02.17.431492

non-human primateexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 31, 2020

The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

D. Li, R. J. Edwards, K. Manne…·Petzol

This study examines SARS-CoV-2 neutralizing and infection-enhancing antibodies, showing in vitro enhancement does not always lead to in vivo disease enhancement, but can cause increased lung inflammation in monkeys.

DOI 10.1101/2020.12.31.424729

humanmouse

𝕏 PostBluesky